Search - tctmd.com

Displaying 1 - 20 of 56

Sort: Relevancy | Date

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Conference News AHA 2024

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

Caitlin E. Cox

November 22, 2024

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

News Conference News TCT 2024

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

L.A. McKeown

October 27, 2024

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Daily News

MI Care Varies Across Asian Subgroups in the US

Yael L. Maxwell

September 19, 2024

News Daily News

AAA-Related Mortality Rates Decline, With Reductions Seen in All Groups

Michael O'Riordan

July 29, 2024

News Daily News

Going Global: Asia-Pacific Region Not Represented in Large Clinical Trials

Todd Neale

July 10, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

News Daily News

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

Caitlin E. Cox

December 12, 2023

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Daily News

‘Astonishing’ Rates of CVD Linked to Lead Exposure

Caitlin E. Cox

September 13, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

L.A. McKeown

July 27, 2023

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

Caitlin E. Cox

December 06, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

Advertisement

Heart Disease Remains Number One Killer of Americans

CVD Still the Leading Cause of Death and Disease Globally

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

October 2024 Dispatch for the CV Team

MI Care Varies Across Asian Subgroups in the US

AAA-Related Mortality Rates Decline, With Reductions Seen in All Groups

Going Global: Asia-Pacific Region Not Represented in Large Clinical Trials

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

December 2023 Dispatch for the CV Team

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

‘Astonishing’ Rates of CVD Linked to Lead Exposure

September 2023 News Roundup

Women and Minorities Underrepresented in Heart Valve Trials

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content